EBR Systems, Inc. · ASX:EBR
EBR Systems — Shareholder Meeting (May 2024)
9 slides from EBR Systems's shareholder meeting presentation, May 30, 2024
Slide 1: 2024 Annual Meeting of Stockholders: Presentation of President & CEO
ASX ANNOUNCEMENT 30 May 2024 2024 Annual Meeting of Stockholders Presentation of President & CEO Sunnyvale, California; 30 May 2024: EBR Systems, Inc. (ASX: “EBR”, “EBR Systems”, or the “Company”), is pleased to provide the presentation of the President & CEO to be delivered at the Company’s virtual
Slide 2: EBR Systems' WiSE Technology and Forward-Looking Statements
Resynchronisation Therapy (CRT). Future products potentially address wireless endocardial stimulation for bradycardia and other non-cardiac indications. EBR Systems’ WiSE Technology EBR Systems’ WiSE technology is the world’s only wireless, endocardial (inside the heart) pacing system in clinical us
Slide 3: AGM Presentation May 2024
For personal use only AGM Presentation MAY 2024
Slide 4: Year in review
Year in review July 2023 For personal use only • EBR completed A$30m placement and A$2.7m SPP1 • Successfully drew down US$20m from growth capital facility • Engaged with investors on Australian roadshow September 2023 • Positive additional results from the SOLVE-CRT study presented at APHRS2 • Appo
Slide 5: Pivotal SOLVE-CRT Study meets primary endpoints
Pivotal SOLVE-CRT Study meets primary endpoints Positive results confirm WiSE CRT System as a highly effective treatment option for patients with heart failure1 For personal use only Primary efficacy endpoint met Primary safety endpoint met -16.4% Decrease in left ventricular end systolic volume (vs
Slide 6: Commercialisation pathway
Commercialisation pathway Positive pivotal trial results support EBR’s regulatory approval process and underpin a clear pathway to commercialisation For personal use only 1 Drive adoption and Confidence in FDA approval process underpinned by positive growth pivotal trial results and a track record o
Slide 7: Investment highlights
Investment highlights EBR is focused on executing its clear and targeted commercialisation strategy to deliver shareholder value For personal use only High value market opportunity De-risked pathways to market Expert leadership Unique solution Large markets Positive results Focused strategy Strong t
Slide 8: Disclaimer
Disclaimer The material contained in this document is a presentation of general information about the activities of EBR Systems, Inc. (ASX:EBR) (ARBN 654 147 127) and its subsidiaries (“EBR”) current as at the date of this presentation. It should be read in conjunction with EBR’s periodic and contin
Slide 9: Contact us
For personal use only Contact us Company John McCutcheon President & CEO P: +1 408 720 1906 E: info@ebrsystemsinc.com Investors Joel Seah Vesparum Capital P: +61 3 8582 4800 E: EBRSystems@vesparum.com